Molecular Partners AG
MOLN • Biotechnology
$4.35
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$166.92M
Growth
-100.0%
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0.05Healthy liquidity · 8.79Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 27, 2026, 12:16 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.35
Change0.00%
Market Cap$166.92M
52W Range3.53 - 5.36
Beta0.68
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.05
Current Ratio8.79
Quick Ratio8.79
Revenue 5Y-100.00%
Price$4.35
Change0.00%
Market Cap$166.92M
52W Range3.53 - 5.36
Beta0.68
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.05
Current Ratio8.79
Quick Ratio8.79
Revenue 5Y-100.00%
Target$21.00
Target Upside382.76%
Target Median$21.00
Target Range13.00 - 29.00
Volume1.73K
Avg Volume4.79K
EPS Surprise-0.07
Investment DNA
How strong this company looks for long-term investors
45
out of 100
Business Quality
Margins, moat, returns
27/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
90/100
Why this score▼
Manageable debt level · 0.05Healthy liquidity · 8.79Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-27
Low
$13.00
Mean
$21.00
Median
$21.00
High
$29.00
🧾
No insider activity
No recent insider transactions available.